Atacand 8 AstraZeneca

All about product
Specification
Reviews
0
Questions
0
Out Of Stock
Product Code: EU10834
Brand: AstraZeneca
Reviews: 0
26.00€
Specifications: (See all)
Acne
No
Active substance
Candesartan Cilexetil
Also known as
Candesartan
Aromatization
No
Blood pressure
Effectively lowers blood pressure
Specifications
Features
Acne
No
Active substance
Candesartan Cilexetil
Also known as
Candesartan
Aromatization
No
Blood pressure
Effectively lowers blood pressure
Chemical name
1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylate
Dosage (medical)
Typically 8-32 mg once daily
Dosage (sports)
Not applicable
Effects
Lowers blood pressure, reduces strain on the heart, may improve survival after heart attacks
Formula
C33H34N6O6
Half-life
Approximately 9 hours
HBR
No
Hepatotoxicity
No
Lab Test
Monitoring of blood pressure and renal function may be required
Main action
Blocks the action of angiotensin II, resulting in vasodilation and reduction in blood pressure
Side effects
Dizziness, headache, back pain, sore throat, abdominal pain, diarrhea
Storage conditions
Store at room temperature, protect from moisture and light
Substance class
Angiotensin II receptor blocker
Trade name
Atacand
Use in sports
Not typically used in sports for performance enhancement
WAREHOUSE
International Warehouse 2
Water Retention
No
Manufacturer
AstraZeneca
Reviews
0 / 5
average product rating
0
0
0
0
0

There are no reviews for this product, be the first to leave your review.

Answers & questions

No questions about this product, be the first and ask your question.

Atacand 8 AstraZeneca
26.00€
Viewed products
IGF1 LR3 1 mg Canada Peptides
In stock
Caberlin Sunrise
In stock
18.00€
Saizen 12 MG (36IU) Merckgroup
In stock
Somatrow HGH cRowX Labs
In stock
Pharma STAN 50 mg Pharmacom Labs
In stock
Peak - Trainbolon 120 tabs Peak Performance
In stock
Glycomet 850 mg USV Private Ltd.
In stock
SOMATROX HGH Zerox Pharmaceuticals
In stock
Euthyrox 150 Merckgroup
In stock